Oncology
From the Journals
Colorectal cancer: Younger patients fare worse
Genetic data also showed increased prevalence of certain mutations in early-onset patients.
Latest News
Imaging techniques will revolutionize cancer detection, expert predicts
Jennifer Barton, PhD, and her colleagues are developing an OCT/fluorescence imaging falloposcope that is 0.8 mm in diameter, flexible, and...
Latest News
Study supports new NCCN classification for cutaneous squamous cell carcinoma
The high- and very-high-risk groups in the NCCN guidelines identify SCCs at greatest risk for developing poor outcomes.
Conference Coverage
CBSM phone app eases anxiety, depression in cancer patients
Few patients with cancer have access to psycho-oncologic support.
From the Journals
Breast cancer family history linked to better BC survival
A family history of breast cancer was associated with a lower risk of breast cancer-specific death, after adjustments, a new study finds.
Latest News
Should race and ethnicity be used in CRC recurrence risk algorithms?
Removing race from clinical risk predictions could lead to higher racial bias in model accuracy and less accurate estimation of risk in some...
Latest News
Few of those eligible get lung cancer screening, despite USPSTF recommendations
Fewer than 13% who are eligible get CT screening. Results highlight the need for education, Medicare coverage, and recognition of stigma’s role,...
Latest News
Prognostic factors of SCCs in organ transplant recipients worse compared with general population
SCCs developed most frequently on the head/neck in organ transplant recipients and on the arms/hands in the general population.
From the Journals
Low-carb, plant-rich diets tied to breast cancer survival?
“Breast cancer survivors could benefit from limiting intake of carbohydrates, especially from fruit juice, sugar-sweetened beverages, and added...
From the Journals
Cognitive decline risk in adult childhood cancer survivors
“We need to educate oncologists and primary care providers on the risks our survivors face long after completion of therapy.”
From the Journals
Ovarian cancer: Sequencing strategy identifies biomarker that could guide treatment
Novel sequencing strategy appears to be a reliable predictor of homologous recombination DNA repair deficiency.